Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 02, 2022 16:15 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Executive Leadership and Board Transitions in Preparation for Commercialization of the iLet® Bionic Pancreas System

Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Dr. Ed Damiano, President & CEO of Beta...
February 17, 2022 16:00 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. The financing round was co-led by existing...
December 22, 2021 07:00 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Data Lock of the Insulin-Only Bionic Pancreas Pivotal Trial and Enrollment into the Screening Protocol of the Bihormonal Bionic Pancreas Pivotal Trial

The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use.Not available for sale. The iLet® Bionic Pancreas is a pocket-sized, wearable...
May 06, 2021 16:00 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

IRVINE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a medical technology company focused on the design, development, and commercialization of the iLet® bionic pancreas system, today...